Polypharmacy among pediatric cancer patients dying in the hospital
CONCLUSIONS: Polypharmacy is ubiquitous among pediatric oncology patients at EOL. Disease type and DNR status may affect medication burden and deprescribing during the last hospitalization.PMID:34251125
Source: The Israel Medical Association Journal - Category: General Medicine Authors: Sharon Tamir Daniel Kurnik Myriam Weyl Ben-Arush Sergey Postovsky Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Children | General Medicine | Israel Health | Leukemia | Lymphoma | Middle East Health | Pediatrics | Study